Search results for " Distal"

showing 2 items of 22 documents

Possible reason for preferential damage to renal tubular epithelial cells evoked by amphotericin B

1996

An important determinant of nephrotoxicity, which is the major complication of long-term amphotericin B treatment, is dysfunction of distal tubular epithelial cells. The underlying cause for this rather selective damage to the cells is unknown. In the present investigation, it was shown that kidney epithelial cells were initially damaged by amphotericin B at concentrations of 2.5 to 10 micrograms/ml, as demonstrable by a dramatic drop in cellular K+ levels. Cells could recover from the initial toxic action of the polyene if they were kept in medium of neutral pH, and cellular K+ levels returned to normal after 6 h. However, the recovery mechanisms failed at lower pHs of 5.6 to 6.0. At low p…

medicine.medical_specialtyAntifungal AgentsLumen (anatomy)PharmacologyBiologyEpitheliumCell LineNephrotoxicitychemistry.chemical_compoundAdenosine TriphosphateAmphotericin BInternal medicineAmphotericin BLactate dehydrogenasemedicineAnimalsPharmacology (medical)Kidney Tubules DistalPharmacologyKidneyL-Lactate DehydrogenaseHydrogen-Ion ConcentrationMacaca mulattaIn vitroEpitheliumInfectious Diseasesmedicine.anatomical_structureEndocrinologychemistryToxicityPotassiumResearch Articlemedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

OC-01 - Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study

2016

Introduction Isolated distal deep vein thrombosis (IDDVT) accounts for one-fourth to one-half of all deep vein thrombosis (DVT) of the leg. Patients with IDDVT are frequently treated for a shorter period of time compared to patients with proximal DVT and/or pulmonary embolism (PE) due to a perceived lower risk of recurrence. About 10-20% of patients with venous thromboembolic events (VTEs) have concomitant cancer. Guidelines recommend long-term anticoagulant treatment in this group of patients due to their high risk of VTE recurrence. Unfortunately, information on the clinical history of IDDVT patients is limited and, to date, no study has evaluated the long-term risk of VTE recurrence in I…

medicine.medical_specialtymedicine.drug_classDeep veinPopulationLow molecular weight heparin030204 cardiovascular system & hematologyLower riskGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinemedicinecancerVeineducationThrombosis history; distal deep vein thrombosis;cancerThrombosis historyeducation.field_of_studybusiness.industrydistal deep vein thrombosiHematologymedicine.diseaseThrombosisPulmonary embolismSurgeryVenous thrombosismedicine.anatomical_structure030220 oncology & carcinogenesisbusinessThrombosis Research
researchProduct